No Data
No Data
JMP Securities Maintains EnGene Holdings(ENGN.US) With Buy Rating, Maintains Target Price $18
A Quick Look at Today's Ratings for EnGene Holdings(ENGN.US), With a Forecast Between $25 to $34
EnGene Holdings Insider Ups Holding During Year
Express News | Morgan Stanley Maintains Overweight on EnGene Holdings, Lowers Price Target to $34
Promising Prospects for EnGene Holdings: Buy Rating on Detalimogene Voraplasmid's Strong Clinical Profile
Express News | HC Wainwright & Co. Reiterates Buy on EnGene Holdings, Maintains $25 Price Target